Skip to content
  • Home
  • Allergen Immunotherapy
    • Glossary of Terms
  • About Us
    • Newsroom
  • Contact

Latest News & Articles

< Back To Newsroom

  • Infectious Disease Solutions

    Malaria and Influenza: How ADBP Can Transform Prevention Strategies

    August 24, 2026
  • Infectious Disease Solutions

    Tackling Tuberculosis with Antigen Delivery by Precipitation: The Science and Potential

    August 24, 2026
  • Infectious Disease Solutions

    The Global Impact of Infectious Diseases: Why Vaccine Platforms Must Evolve

    August 24, 2026

1122 N. High Street,
Millville, NJ 08332-2529

Contact Us >

BOME’s immunotherapy is currently not FDA approved. We are in the process of further product refinement and hope to conduct clinical trials in the near future.

Page load link
Go to Top